ADVI’s Marc Samuels and Lindsay Bealor Greenleaf shared insights on the CMS Medicaid final rule policies related to copay coupons and value based arrangements with BioWorld Read the full article here.
Read moreA Biden win, a Republican Senate and a slim Democratic majority in the House: That’s a recipe for compromise. Read the full article here.
Read moreTexas Oncology’s Dr. Debra Patt weighed in with Fierce Healthcare on where the oncology ecosystem stands on the Trump administration’s most-favored-nation final rule Read the full article here.
Read moreADVI Health estimates year one of the Most Favored Nations (MFN) Model could cut Part B drug payments by $4.2 Billion.
Read more